Free Trial

AVITA Medical (RCEL) Earnings Date, Estimates & Call Transcripts

AVITA Medical logo
$11.77 +0.29 (+2.53%)
(As of 12/20/2024 05:30 PM ET)

AVITA Medical Latest Earnings Summary

Actual EPS
(Nov. 7)
-$0.62 Missed By -$0.21
Consensus EPS
(Nov. 7)
-$0.41

AVITA Medical issued Q3 2024 earnings on November 7, 2024, reporting an EPS of -$0.62, which missed the consensus estimate of -$0.41 by $0.21. Quarterly revenue was reported to be $19.55 million, below the consensus estimate of $19.65 million. With a trailing EPS of -$2.23, AVITA Medical's earnings are expected to grow next year, from ($2.35) to ($1.36) per share.

Get AVITA Medical Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AVITA Medical and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

RCEL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RCEL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

AVITA Medical Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241-$0.43-$0.43-$0.43 
Q2 20241-$0.44-$0.44-$0.44 

AVITA Medical Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/7/2024Q3 2024-$0.41-$0.62 -$0.21-$0.62$19.65M$19.55M
8/8/2024Q2 2024-$0.59-$0.60 -$0.01-$0.60$15.04M$15.20M
5/13/2024Q1 2024-$0.26-$0.73 -$0.47-$0.73$11.08M$11.10M
2/22/2024Q4 2023-$0.34-$0.28+$0.06-$0.28$14.10M$14.20M
11/9/2023Q3 2023-$0.53-$0.34+$0.19-$0.34-$13.65M
8/10/2023Q2 2023-$0.34-$0.41 -$0.07-$0.41$11.20M$11.75M
5/11/2023Q1 2023-$0.22-$0.37 -$0.15-$0.37$10.52M$10.55M
2/23/2023Q4 2022-$0.32-$0.21+$0.11-$0.21$8.67M$9.46M

AVITA Medical Earnings - Frequently Asked Questions

AVITA Medical (NASDAQ:RCEL) last announced its quarterly earning data on Thursday, November 7, 2024. Learn more on RCEL's earnings history.

AVITA Medical issued an update on its fourth quarter 2024 earnings guidance on Thursday, November, 7th. The company issued revenue guidance of $22.3 million-$24.3 million, compared to the consensus revenue estimate of $23.1 million.

In the previous quarter, AVITA Medical (NASDAQ:RCEL) missed the analysts' consensus estimate of ($0.41) by $0.21 with a reported earnings per share (EPS) of ($0.62). Learn more on analysts' earnings estimate vs. RCEL's actual earnings.

The conference call for AVITA Medical's latest earnings report can be listened to online.
Listen to Conference Call

AVITA Medical (NASDAQ:RCEL) has a recorded annual revenue of $60.04 million.

AVITA Medical (NASDAQ:RCEL) has a recorded net income of -$35.38 million. RCEL has generated -$2.23 earnings per share over the last four quarters.

AVITA Medical's earnings are expected to grow from ($2.35) per share to ($1.36) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:RCEL) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners